Skip to main content
Top
Published in: Supportive Care in Cancer 1/2020

01-01-2020 | Mood Disorders | Original Article

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

Authors: Heide Götze, Michael Friedrich, Sabine Taubenheim, Andreas Dietz, Florian Lordick, Anja Mehnert

Published in: Supportive Care in Cancer | Issue 1/2020

Login to get access

Abstract

Purpose

Our study provides data on depression and anxiety in long-term cancer survivors, in men, women and various age groups, as well as identifies associated factors and coping-related resources.

Methods

We present data obtained from 1002 cancer survivors across a large variety of tumour entities 5 years (cohort 1) and 10 years (cohort 2) after diagnosis, in a cross-sectional study. We analysed depression (PHQ-9) and anxiety (GAD-7) symptomatology in comparison with two large age- and sex-matched samples randomly selected from the general population.

Results

Moderate to severe depression and anxiety were reported in 17% and 9% of cancer survivors, respectively. There were no significant differences between the 5 years and 10 years after diagnosis cohorts (p = 0.232). In both cohorts, we found higher depression and anxiety in women than in men (p < 0.001), and lower depression and anxiety in elderly patients (p < 0.001). Cancer survivors younger than 60 years of age were more depressed and anxious than the general population (p < 0.001). The variables, financial problems (Beta = 0.16, p < 0.001), global quality of life (Beta = − 0.21, p < 0.001) and cognitive function (Beta = − 0.30, p < 0.001), had the strongest association with depression and anxiety.

Conclusions

For the prevention of depression and anxiety in long-term cancer survivors, individual treatment of physical and psychological symptoms is as important as social support and professional counselling. Post-treatment, cognitive limitations should be carefully assessed in long-term cancer survivorship to distinguish them from symptoms of a mental disorder, especially since younger cancer survivors of working age and female survivors seem to be more affected by depression and anxiety.
Literature
1.
go back to reference Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH et al (2006) Cancer in the elderly. Trans Am Clin Climatol Assoc 117:147–155 discussion 155-6PubMedPubMedCentral Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH et al (2006) Cancer in the elderly. Trans Am Clin Climatol Assoc 117:147–155 discussion 155-6PubMedPubMedCentral
2.
go back to reference Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, Forsythe LP, Rowland JH (2015) The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv 9(2):239–251CrossRef Leach CR, Weaver KE, Aziz NM, Alfano CM, Bellizzi KM, Kent EE, Forsythe LP, Rowland JH (2015) The complex health profile of long-term cancer survivors: prevalence and predictors of comorbid conditions. J Cancer Surviv 9(2):239–251CrossRef
3.
go back to reference Wu H, Harden JK (2015) Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs 38(1):E29–E54CrossRef Wu H, Harden JK (2015) Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs 38(1):E29–E54CrossRef
4.
go back to reference Walsh K (2016) Addressing psychosocial issues in cancer survivorship: past, present and future. Future Oncol 12:2823–2834CrossRef Walsh K (2016) Addressing psychosocial issues in cancer survivorship: past, present and future. Future Oncol 12:2823–2834CrossRef
5.
go back to reference Salz T, Baxi S (2016) Moving survivorship care plans forward: focus on care coordination. Cancer Med 5(7):1717–1722CrossRef Salz T, Baxi S (2016) Moving survivorship care plans forward: focus on care coordination. Cancer Med 5(7):1717–1722CrossRef
6.
go back to reference Foster C, Wright D, Hill H, Hopkinson J, Roffe L (2009) Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eur J Cancer Care (Engl) 18(3):223–247CrossRef Foster C, Wright D, Hill H, Hopkinson J, Roffe L (2009) Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Eur J Cancer Care (Engl) 18(3):223–247CrossRef
7.
go back to reference Hartung TJ, Brahler E, Faller H, Harter M, Hinz A, Johansen C et al (2017) The risk of being depressed is significantly higher in cancer patients than in the general population: prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer 72:46–53CrossRef Hartung TJ, Brahler E, Faller H, Harter M, Hinz A, Johansen C et al (2017) The risk of being depressed is significantly higher in cancer patients than in the general population: prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer 72:46–53CrossRef
8.
go back to reference Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 Suppl):2577–2592CrossRef Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 Suppl):2577–2592CrossRef
9.
go back to reference Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors--a systematic review. Int J Psychiatry Med 40(2):163–181CrossRef Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It’s not over when it’s over: long-term symptoms in cancer survivors--a systematic review. Int J Psychiatry Med 40(2):163–181CrossRef
10.
go back to reference Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P (2013) Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 14(8):721–732CrossRef Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P (2013) Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 14(8):721–732CrossRef
11.
go back to reference Sharp L, O’Leary E, Kinnear H, Gavin A, Drummond FJ (2016) Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psychooncology 25(3):282–291CrossRef Sharp L, O’Leary E, Kinnear H, Gavin A, Drummond FJ (2016) Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psychooncology 25(3):282–291CrossRef
12.
go back to reference Romito F, Cormio C, Giotta F, Colucci G, Mattioli V (2012) Quality of life, fatigue and depression in Italian long-term breast cancer survivors. Support Care Cancer 20(11):2941–2948CrossRef Romito F, Cormio C, Giotta F, Colucci G, Mattioli V (2012) Quality of life, fatigue and depression in Italian long-term breast cancer survivors. Support Care Cancer 20(11):2941–2948CrossRef
13.
go back to reference Krauß O, Ernst J, Kuchenbecker D, Hinz A, Schwarz R (2007) Prädiktoren psychischer Störungen bei Tumorpatienten: Empirische Befunde. Psychother Psychosom Med Psychol 57(7):273–280CrossRef Krauß O, Ernst J, Kuchenbecker D, Hinz A, Schwarz R (2007) Prädiktoren psychischer Störungen bei Tumorpatienten: Empirische Befunde. Psychother Psychosom Med Psychol 57(7):273–280CrossRef
14.
go back to reference Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J (2017) Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. Support Care Cancer 25:3171–3179CrossRef Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J (2017) Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study. Support Care Cancer 25:3171–3179CrossRef
16.
go back to reference Lee J, Lee M, Hong S, Kim JY, Park H, Oh M, in Yang H, Kang DW, Park J, Kim DI, Chu S, Lee J, Hur H, Kim NK, Jeon JY (2015) Association between physical fitness, quality of life, and depression in stage II-III colorectal cancer survivors. Support Care Cancer 23(9):2569–2577CrossRef Lee J, Lee M, Hong S, Kim JY, Park H, Oh M, in Yang H, Kang DW, Park J, Kim DI, Chu S, Lee J, Hur H, Kim NK, Jeon JY (2015) Association between physical fitness, quality of life, and depression in stage II-III colorectal cancer survivors. Support Care Cancer 23(9):2569–2577CrossRef
17.
go back to reference von Ah D, Russell KM, Storniolo AM, Carpenter JS (2009) Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncol Nurs Forum 36(3):326–336CrossRef von Ah D, Russell KM, Storniolo AM, Carpenter JS (2009) Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncol Nurs Forum 36(3):326–336CrossRef
18.
go back to reference Danese MD, O’Malley C, Lindquist K, Gleeson M, Griffiths RI (2012) An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol 23(7):1756–1765CrossRef Danese MD, O’Malley C, Lindquist K, Gleeson M, Griffiths RI (2012) An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol 23(7):1756–1765CrossRef
19.
go back to reference Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ (2012) Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomark Prev 21(7):1115–1125CrossRef Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ (2012) Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomark Prev 21(7):1115–1125CrossRef
20.
go back to reference Kocalevent R, Hinz A, Brähler E (2013) Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry 35(5):551–555CrossRef Kocalevent R, Hinz A, Brähler E (2013) Standardization of the depression screener patient health questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry 35(5):551–555CrossRef
21.
go back to reference Hinz A, Klein AM, Brähler E, Glaesmer H, Luck T, Riedel-Heller SG, Wirkner K, Hilbert A (2017) Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J Affect Disord 210:338–344CrossRef Hinz A, Klein AM, Brähler E, Glaesmer H, Luck T, Riedel-Heller SG, Wirkner K, Hilbert A (2017) Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. J Affect Disord 210:338–344CrossRef
22.
go back to reference Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282(18):1737–1744CrossRef Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282(18):1737–1744CrossRef
23.
go back to reference Gräfe K, Zipfel S, Herzog W, Löwe B (2004) Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Diagnostica 50(4):171–181CrossRef Gräfe K, Zipfel S, Herzog W, Löwe B (2004) Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Diagnostica 50(4):171–181CrossRef
24.
go back to reference Bayliss EA, Ellis JL, Steiner JF (2005) Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument. Health Qual Life Outcomes 3:51CrossRef Bayliss EA, Ellis JL, Steiner JF (2005) Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument. Health Qual Life Outcomes 3:51CrossRef
25.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376CrossRef
26.
go back to reference Borenstein M (2012) Introduction to meta-analysis. Wiley, Chichester Borenstein M (2012) Introduction to meta-analysis. Wiley, Chichester
27.
go back to reference Faller H, Brahler E, Harter M, Keller M, Schulz H, Wegscheider K et al (2015) Performance status and depressive symptoms as predictors of quality of life in cancer patients. A structural equation modeling analysis. Psychooncology 24(11):1456–1462CrossRef Faller H, Brahler E, Harter M, Keller M, Schulz H, Wegscheider K et al (2015) Performance status and depressive symptoms as predictors of quality of life in cancer patients. A structural equation modeling analysis. Psychooncology 24(11):1456–1462CrossRef
28.
go back to reference Willems RA, Mesters I, Lechner L, Kanera IM, Bolman CAW (2017) Long-term effectiveness and moderators of a web-based tailored intervention for cancer survivors on social and emotional functioning, depression, and fatigue: randomized controlled trial. J Cancer Surviv 11(6):691–703CrossRef Willems RA, Mesters I, Lechner L, Kanera IM, Bolman CAW (2017) Long-term effectiveness and moderators of a web-based tailored intervention for cancer survivors on social and emotional functioning, depression, and fatigue: randomized controlled trial. J Cancer Surviv 11(6):691–703CrossRef
29.
go back to reference Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K (2015) Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study. Psychooncology 24(1):40–46CrossRef Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K (2015) Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study. Psychooncology 24(1):40–46CrossRef
30.
go back to reference Hall DL, Mishel MH, Germino BB (2014) Living with cancer-related uncertainty: associations with fatigue, insomnia, and affect in younger breast cancer survivors. Support Care Cancer 22(9):2489–2495CrossRef Hall DL, Mishel MH, Germino BB (2014) Living with cancer-related uncertainty: associations with fatigue, insomnia, and affect in younger breast cancer survivors. Support Care Cancer 22(9):2489–2495CrossRef
31.
go back to reference Askren MK, Jung M, Berman MG, Zhang M, Therrien B, Peltier S, Ossher L, Hayes DF, Reuter-Lorenz PA, Cimprich B (2014) Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Treat 147(2):445–455CrossRef Askren MK, Jung M, Berman MG, Zhang M, Therrien B, Peltier S, Ossher L, Hayes DF, Reuter-Lorenz PA, Cimprich B (2014) Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Treat 147(2):445–455CrossRef
32.
go back to reference Jung MS, Visovatti M (2017) Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma. Support Care Cancer 25(3):915–923CrossRef Jung MS, Visovatti M (2017) Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma. Support Care Cancer 25(3):915–923CrossRef
33.
go back to reference Demark-Wahnefried W, Rogers LQ, Alfano CM, Thomson CA, Courneya KS, Meyerhardt JA et al (2015) Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin 65(3):167–189CrossRef Demark-Wahnefried W, Rogers LQ, Alfano CM, Thomson CA, Courneya KS, Meyerhardt JA et al (2015) Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin 65(3):167–189CrossRef
34.
go back to reference Kalter J, Buffart LM, Korstjens I, van Weert E, Brug J, Verdonck-de Leeuw IM, Mesters I, van den Borne B, Hoekstra-Weebers JEHM, Ros WJG, May AM (2015) Moderators of the effects of group-based physical exercise on cancer survivors’ quality of life. Support Care Cancer 23(9):2623–2631CrossRef Kalter J, Buffart LM, Korstjens I, van Weert E, Brug J, Verdonck-de Leeuw IM, Mesters I, van den Borne B, Hoekstra-Weebers JEHM, Ros WJG, May AM (2015) Moderators of the effects of group-based physical exercise on cancer survivors’ quality of life. Support Care Cancer 23(9):2623–2631CrossRef
35.
go back to reference Ashing-Giwa KT, Lim J (2009) Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum 36(1):79–88CrossRef Ashing-Giwa KT, Lim J (2009) Examining the impact of socioeconomic status and socioecologic stress on physical and mental health quality of life among breast cancer survivors. Oncol Nurs Forum 36(1):79–88CrossRef
36.
go back to reference Gordon BE, Chen RC (2017) Patient-reported outcomes in cancer survivorship. Acta Oncol 56(2):166–173CrossRef Gordon BE, Chen RC (2017) Patient-reported outcomes in cancer survivorship. Acta Oncol 56(2):166–173CrossRef
37.
go back to reference Andersen BL, Golden-Kreutz DM, Emery CF, Thiel DL (2009) Biobehavioral intervention for cancer stress: conceptualization, components, and intervention strategies. Cogn Behav Pract 16(3):253–265CrossRef Andersen BL, Golden-Kreutz DM, Emery CF, Thiel DL (2009) Biobehavioral intervention for cancer stress: conceptualization, components, and intervention strategies. Cogn Behav Pract 16(3):253–265CrossRef
38.
go back to reference Stafford L, Komiti A, Bousman C, Judd F, Gibson P, Mann GB, Quinn M (2016) Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer. Breast 26:100–105CrossRef Stafford L, Komiti A, Bousman C, Judd F, Gibson P, Mann GB, Quinn M (2016) Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer. Breast 26:100–105CrossRef
39.
go back to reference Jacob L, Bleicher L, Kostev K, Kalder M (2016) Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. J Cancer Res Clin Oncol 142(2):447–452CrossRef Jacob L, Bleicher L, Kostev K, Kalder M (2016) Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. J Cancer Res Clin Oncol 142(2):447–452CrossRef
Metadata
Title
Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis
Authors
Heide Götze
Michael Friedrich
Sabine Taubenheim
Andreas Dietz
Florian Lordick
Anja Mehnert
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04805-1

Other articles of this Issue 1/2020

Supportive Care in Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine